Correlation Between Beta Drugs and Tribhovandas Bhimji

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Tribhovandas Bhimji at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Tribhovandas Bhimji into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beta Drugs and Tribhovandas Bhimji Zaveri, you can compare the effects of market volatilities on Beta Drugs and Tribhovandas Bhimji and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Tribhovandas Bhimji. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Tribhovandas Bhimji.

Diversification Opportunities for Beta Drugs and Tribhovandas Bhimji

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Beta and Tribhovandas is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Tribhovandas Bhimji Zaveri in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tribhovandas Bhimji and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Tribhovandas Bhimji. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tribhovandas Bhimji has no effect on the direction of Beta Drugs i.e., Beta Drugs and Tribhovandas Bhimji go up and down completely randomly.

Pair Corralation between Beta Drugs and Tribhovandas Bhimji

Assuming the 90 days trading horizon Beta Drugs is expected to generate 0.98 times more return on investment than Tribhovandas Bhimji. However, Beta Drugs is 1.02 times less risky than Tribhovandas Bhimji. It trades about -0.11 of its potential returns per unit of risk. Tribhovandas Bhimji Zaveri is currently generating about -0.16 per unit of risk. If you would invest  220,000  in Beta Drugs on December 2, 2024 and sell it today you would lose (55,060) from holding Beta Drugs or give up 25.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Beta Drugs  vs.  Tribhovandas Bhimji Zaveri

 Performance 
       Timeline  
Beta Drugs 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Beta Drugs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Tribhovandas Bhimji 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tribhovandas Bhimji Zaveri has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Beta Drugs and Tribhovandas Bhimji Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beta Drugs and Tribhovandas Bhimji

The main advantage of trading using opposite Beta Drugs and Tribhovandas Bhimji positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Tribhovandas Bhimji can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tribhovandas Bhimji will offset losses from the drop in Tribhovandas Bhimji's long position.
The idea behind Beta Drugs and Tribhovandas Bhimji Zaveri pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stocks Directory
Find actively traded stocks across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance